Latest news with #NationalDigitalHealthMission
Yahoo
04-06-2025
- Business
- Yahoo
Business Opportunities in Asia-Pacific's USD 215.5 Billion Telemedicine Market, 2033
Key contributors include China's smart healthcare initiatives, India's National Digital Health Mission, and increased smartphone penetration. Major market players like Cisco, General Electric, and Teladoc Health are innovating within the sector, despite challenges like data privacy concerns and the integration of telemedicine with traditional healthcare systems. Asia-Pacific Telemedicine Market Dublin, June 04, 2025 (GLOBE NEWSWIRE) -- The "Asia-Pacific Telemedicine Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" has been added to Asia-Pacific Telemedicine Market is expected to reach US$ 215.53 billion by 2033 from US$ 28.51 billion in 2024, with a CAGR of 25.2% from 2025 to 2033. The growing need for remote healthcare services, better access to healthcare in underserved areas, and developments in telehealth technology and telecommunications infrastructure are the main factors propelling the Asia-Pacific telemedicine market. The necessity for remote healthcare solutions, technical improvements, and growing healthcare demand have all contributed to the Asia-Pacific telemedicine industry's recent notable expansion. Due to the region's high population, fast urbanization, and unequal access to medical resources, telemedicine has become an essential tool for increasing access to healthcare. With significant investments in digital health infrastructure, nations like China, India, Japan, South Korea, and Australia are at the forefront. Adoption has been further encouraged by government programs like China's push for smart healthcare and India's National Digital Health Mission. In order to meet the region's varied needs, market participants are always coming up with new services, such as remote diagnostics, virtual consultations, and AI-powered health monitoring. Cloud-based systems, wearable technology, and mobile health apps are increasingly essential to patient care. There are still issues, though, such as inconsistent internet connectivity in remote areas, fragmented regulations, and data privacy issues. Notwithstanding these obstacles, the Asia-Pacific telemedicine market is anticipated to keep growing because to factors including increased awareness, rising smartphone penetration, and rising healthcare spending. A hybrid approach that combines in-person and digital treatment is probably going to take the lead as the sector develops, increasing the reach and effectiveness of medical service delivery. Furthermore, a number of mHealth applications are being adopted more frequently in the Asia-Pacific area to track health outcomes due to the growing prevalence of chronic diseases. In India, for example, the estimated prevalence of cardiovascular diseases (CVDs) was 54.5 million, and one in four deaths are attributed to CVDs, with ischemic heart disease and stroke accounting for over 80% of this burden, according to a 2019 study published in the Journal for Cardiovascular Quality and Outcomes. As a result, the telemedicine market is expanding due to the rising acceptance of these services brought about by the aforementioned market development reasons. Growth Drivers for the Asia-Pacific Telemedicine Market Rising Healthcare Demand: One major factor propelling the expansion of telemedicine in the Asia-Pacific area is the growing demand for healthcare services. The region's healthcare systems are under more strain due to a fast-expanding population and a notable increase in elderly demographics. Furthermore, chronic diseases like diabetes, high blood pressure, and cardiovascular disorders are becoming more common, particularly in cities where people lead sedentary lives and alter their diets. More continuous, affordable, and easily available healthcare services are becoming necessary as a result of these causes. By providing timely medical interventions, chronic illness management, and remote consultations without requiring in-person visits, telemedicine tackles these issues. Through regular monitoring and follow-up care, this model promotes improved health outcomes and expands access to healthcare, particularly in underserved and rural areas. Government Initiatives and Policies: Telemedicine adoption in the Asia-Pacific area is being accelerated in large part by government initiatives and supportive regulations. To increase the efficiency and accessibility of healthcare, nations are making significant investments in digital health infrastructure. For example, the National Digital Health Mission (NDHM) of India seeks to establish a single digital health ecosystem that includes teleconsultation services and electronic health records. As part of its larger digital transformation agenda, China is also making significant investments in smart healthcare technology, encouraging big data, AI, and 5G-enabled medical services. Favorable telehealth financing and laws are also being introduced in other countries, such as Australia, South Korea, and Japan. Through these proactive government initiatives, telemedicine is becoming a viable component of national healthcare systems, encouraging innovation, and guaranteeing data security. Increased Smartphone and Internet Penetration: Access to telemedicine services is being greatly increased by the quick rise in smartphone and internet usage in Asia-Pacific emerging markets. Even in semi-urban and rural areas, mobile device adoption and reasonably priced internet connectivity have increased in countries like the Philippines, Indonesia, and India. By removing conventional obstacles like distance and a lack of medical infrastructure, this digital development has allowed millions of people to communicate with healthcare providers remotely. Particularly for younger, tech-savvy populations, mobile health apps, video consultations, and online pharmacies are now more accessible than ever. Telehealth use is anticipated to increase as digital literacy improves, making healthcare more accessible, effective, and inclusive for underprivileged areas. Challenges in the Asia-Pacific Telemedicine Market Data Privacy and Security Concerns: Concerns about data security and privacy continue to be major obstacles in the Asia-Pacific telemedicine business. To prevent data breaches and unauthorized access, strict protections must be in place when processing and storing sensitive patient data, including medical histories, diagnostic results, and personal identifiers. However, for telehealth providers who operate in numerous nations, the region's disparate data protection rules provide challenges. The absence of standardized privacy laws or thorough cybersecurity frameworks in many countries raises the possibility of non-compliance and legal problems. Concerns regarding data control and transparency are also raised by the expanding usage of cloud platforms and third-party apps. Strong data encryption, transparent permission procedures, and uniform regulatory requirements are crucial for fostering user confidence and guaranteeing safe telemedicine operations in all of the region's marketplaces. Integration with Traditional Healthcare Systems: In the Asia-Pacific area, integrating telemedicine into conventional healthcare systems is a difficult and resource-intensive task. It is challenging to coordinate workflows and communicate data seamlessly since many healthcare providers continue to use outdated systems that are incompatible with contemporary telehealth platforms. Integration attempts are made more difficult by the lack of standardized electronic health record (EHR) systems among clinics and hospitals. Healthcare workers may also need to devote time, money, and training to overcome a learning curve while adjusting to new digital tools. Furthermore, strong interoperability and coordination amongst numerous stakeholders are necessary to guarantee continuity of care between in-person and virtual visits. Telemedicine runs the danger of functioning independently without seamless integration, which would reduce its efficacy and long-term viability within the larger healthcare delivery ecosystem. Key Attributes Report Attribute Details No. of Pages 200 Forecast Period 2024-2033 Estimated Market Value (USD) in 2024 $28.51 Billion Forecasted Market Value (USD) by 2033 $215.53 Billion Compound Annual Growth Rate 25.2% Regions Covered Asia-Pacific Key Topics Covered1. Introduction2. Research & Methodology3. Executive Summary4. Market Dynamics4.1 Growth Drivers4.2 Challenges5. Asia-Pacific Telemedicine Market5.1 Historical Market Trends5.2 Market Forecast6. Market Share6.1 By Types6.2 By Application6.3 By End User6.4 By Countries7. Types7.1 Product7.2 Services8. Application8.1 Teleconsultation8.2 Telepathology8.3 Telecardiology8.4 Telesurgery8.5 Teleradiology8.6 Teledermatology8.7 Telepsychiatry8.8 Others9. End User9.1 Hospital9.2 Diagnostic Center9.3 Ambulatory Surgical Center9.4 Specialty Center9.5 Others10. Countries10.1 China10.2 Japan10.3 India10.4 South Korea10.5 Thailand10.6 Malaysia10.7 Indonesia10.8 Australia10.9 New Zealand10.10 Rest of Asia-Pacific11. Porter's Five Forces Analysis11.1 Bargaining Power of Buyers11.2 Bargaining Power of Suppliers11.3 Degree of Rivalry11.4 Threat of New Entrants11.5 Threat of Substitutes12. SWOT Analysis12.1 Strength12.2 Weakness12.3 Opportunity12.4 Threat13. Key Players Analysis13.1 Cisco System13.2 General Electric Company13.3 Eli Lilly and Company13.4 Bayer AG13.5 Honeywell International Inc.13.6 Merck & Co Inc.13.7 Teladoc Health, Inc.13.8 Twilio more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Asia-Pacific Telemedicine Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
26-05-2025
- Health
- Yahoo
India Diabetes Care Market Analysis Report 2025-2030: Insulin Segment Leads India's Expanding Diabetes Market as Pharma Giants Scale Up Production
India's diabetes care market is poised for robust expansion, driven by rising diabetes prevalence, government initiatives, and technological advancements. With the country holding the second-highest number of diabetes cases globally, the market, valued at INR 1.25 trillion in 2024, is projected to reach INR 1.87 trillion by 2030, achieving a CAGR of 7.96%. Notable trends include the rise of AI-powered health platforms, digital therapeutics, and a shift towards home-based care solutions, despite challenges in accessibility and regulatory hurdles. Dublin, May 26, 2025 (GLOBE NEWSWIRE) -- The "Diabetes Care Market in India (2025-2030" report has been added to diabetes care market in India was valued at INR 1.25 trillion in 2024 and is expected to reach INR 1.87 trillion by 2030 expanding at a compound annual growth rate (CAGR) of 7.96% during the 2025 - 2030 period. India has the second-highest number of diabetes cases globally, with a rapidly increasing prevalence due to lifestyle changes, urbanization, and genetic predisposition. The diabetes care market in India is expanding significantly, driven by rising healthcare awareness, technological advancements, and government initiatives. Between 2025 and 2030, the market is expected to witness robust growth, with a surge in demand for diabetes management solutions, including digital health platforms, insulin delivery devices, and non-invasive glucose monitoring market is fuelled by an increasing patient pool, improved healthcare infrastructure, and innovative product offerings. As of 2025, over 100 million Indians are expected to be diagnosed with diabetes, creating a multi-billion-dollar market for diabetes management solutions. The insulin segment dominates the market, with leading pharmaceutical companies such as Novo Nordisk, Sanofi, and Biocon expanding their manufacturing capabilities. Digital health solutions, including AI-powered glucose monitoring and telemedicine platforms, are gaining traction. The Government of India's Ayushman Bharat scheme and National Digital Health Mission (NDHM) are facilitating better access to diabetes care, further accelerating market influencers:The diabetes care market in India is influenced by several drivers and challenges shaping its growth trajectory. Key market drivers include government initiatives such as Ayushman Bharat and the expansion of the Government e-Marketplace (GeM), which has simplified procurement for diabetes-related medical devices in public healthcare settings. The rising prevalence of diabetes, projected to reach 136 million cases by 2030, is creating a surge in demand for advanced diabetes management solutions. Additionally, technological advancements, including AI-powered glucose monitoring and wearable insulin pumps, are transforming diabetes care by offering real-time tracking and personalized treatment plans. The expansion of private healthcare providers and specialty diabetes clinics across India is also strengthening the market by improving accessibility to the market faces significant challenges. The high cost of advanced diabetes management solutions, such as continuous glucose monitoring (CGM) devices and automated insulin delivery systems, limits adoption among middle- and lower-income populations. Despite efforts like the Pradhan Mantri Jan Aushadhi Yojana, which aims to provide affordable medicines, rural areas still struggle with limited access to specialized diabetes care. Moreover, regulatory hurdles, including lengthy approval processes for new diabetes drugs and devices, slow down innovation and market entry for international and domestic players. These factors present both opportunities and obstacles for stakeholders in the diabetes care trends:The diabetes care market in India is experiencing significant trends that are shaping its future. One key trend is the rise of digital therapeutics, with AI-driven mobile applications such as BeatO and Wellthy Therapeutics gaining traction. These apps integrate real-time monitoring, predictive analytics, and virtual consultations, enhancing diabetes management and patient engagement. Another emerging trend is the shift towards home-based diabetes care, driven by increased adoption of self-monitoring blood glucose (SMBG) devices and telemedicine services, especially post-pandemic. This trend is improving accessibility to diabetes care solutions beyond urban Topics Covered: Chapter 1: Executive SummaryChapter 2: Socio-economic IndicatorsChapter 3: Introduction3.1. Market Definition and StructureChapter 4: Market Overview4.1. Diabetes Care Market in India - An Overview4.1.1. Market Size and Growth Forecast Based on Value (2024 - 2030e)Chapter 5: Market Influencers5.1. Market Growth Drivers5.2. Market ChallengesChapter 6: Market Opportunities6.1. Unlocking Growth Potential in Rural Diabetes Care6.2. Public-private partnerships (PPP) Driving Growth in Diabetes Care in IndiaChapter 7: Government Initiatives7.1. Key Initiatives by the Government that Support the Diabetes Care Market in IndiaChapter 8: Market Trends8.1. Key Market TrendsChapter 9: Competitive landscape9.1. Novartis India Limited Company information Business description Products/Services Key people Financial snapshot Key ratios Key financial performance indicators Key business segments Key geographic segments 9.2. Sanofi India Limited9.3. USV Private Limited9.4. BD India Private Limited9.5. Eli Lilly and Company (India) Private Limited9.6. Health Arx Technologies Private Limited9.7. India Medtronic Private Limited9.8. Merck India9.9. Novo Nordisk India Private Limited9.10. Roche Products (India) Private LimitedChapter 10: Emerging Startups10.1. Emerging Start-ups in India's Diabetes Care MarketChapter 11: Recent Developments For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Hans India
11-05-2025
- Health
- Hans India
India's radiology sector booms with AI and remote monitoring advancements
India is witnessing a sharp surge in the adoption of diagnostic radiology devices, with cutting-edge technologies like AI and remote monitoring reshaping the landscape of medical imaging, according to a recent report by tech-enabled market intelligence firm 1Lattice. The report highlights that the country has registered over 1.48 lakh radiology devices, with Maharashtra (20,590), Tamil Nadu (15,267), and Uttar Pradesh (12,236) leading in equipment deployment. This surge reflects India's growing focus on digitisation and modernisation of healthcare services, even extending to semi-urban and rural regions. 'Radiology is evolving from being a hospital-based specialty to a cornerstone of primary and preventive care,' said Sanjay Sachdeva, Director of Healthcare and Lifesciences at 1Lattice. 'The convergence of AI, portability, and remote monitoring is unlocking access, improving accuracy, and reshaping the delivery of diagnostics across India's healthcare system,' he added. AI-powered Remote Patient Monitoring (RPM) tools are now playing a pivotal role in enhancing diagnostic efficiency. These tools enable real-time health tracking and reduce the dependency on in-person visits, improving patient convenience and expanding healthcare reach. India's radiology equipment market is set to grow robustly, projected to increase from $7.1 billion in FY2025 to $13.5 billion by FY2030 — a compound annual growth rate (CAGR) of 10 per cent. This outpaces the global radiology market, which is expected to grow from $34 billion in 2025 to $43 billion by 2030 at a 5 per cent CAGR. Key growth drivers include advancements in digital radiography and ultrasound, rising incidences of chronic diseases such as cancer and cardiovascular conditions, and government initiatives like Ayushman Bharat and the National Digital Health Mission (NDHM). However, challenges remain. High costs of advanced equipment, disparities in access between urban and rural regions, and concerns over radiation exposure continue to pose hurdles. Despite these, radiology is poised to become a cornerstone of India's tech-driven, decentralised healthcare future, delivering timely and accurate diagnoses across the population.
Hans India
09-05-2025
- Health
- Hans India
AI-led innovation driving growth in India's radiology sector: Report
India is witnessing a significant uptick in the adoption of diagnostic radiology devices, with a major rise in accelerated adoption of AI-powered technologies and remote monitoring solutions, according to a report on Friday. The report by 1Lattice, a tech-enabled market intelligence firm, also attributed the growth to rising disease burden, increased investment in healthcare infrastructure. It revealed that India has registered 1.48 lakh radiology devices, with Maharashtra (20,590), Tamil Nadu (15,267), and Uttar Pradesh (12,236) leading the charge. These figures reflect a broader trend toward modernisation and digitisation of diagnostic services, even beyond urban centres. 'Radiology is evolving from being a hospital-based specialty to a cornerstone of primary and preventive care. The convergence of AI, portability, and remote monitoring is unlocking access, improving accuracy, and reshaping the delivery of diagnostics across India's healthcare system,' said Sanjay Sachdeva, Director - Healthcare and Lifesciences, 1Lattice. Radiology's impact is further enhanced by AI-powered Remote Patient Monitoring (RPM), enabling real-time tracking and reducing the need for frequent in-person visits through remote health monitoring. Globally, the radiology equipment market is poised for strong growth. The global market is projected to rise from $34 billion in 2025 to $43 billion by 2030, reflecting a 5 per cent CAGR. On the other hand, the Indian radiology equipment market is poised to grow from $7.1 billion in FY2025 to $13.5 billion by FY2030, outpacing global growth with a 10 per cent CAGR, the report said. The growth drivers include technological advancements in digital radiography and ultrasound; a rise in chronic diseases such as cancer and cardiovascular conditions; government schemes like Ayushman Bharat and the National Digital Health Mission (NDHM). As healthcare delivery in India becomes more decentralised and tech-driven, radiology will be central to driving outcomes through timely and accurate diagnosis. However, the sector still faces challenges, including the high cost of advanced equipment, uneven access between urban and rural areas, and ongoing concerns around radiation exposure, the report said.
Hindustan Times
02-05-2025
- Health
- Hindustan Times
How AI startups are redefining Indian health care
Artificial Intelligence (AI) in present-day force is reshaping industries, and health care is at the forefront of this transformation. In India, where the sheer scale and complexity of the health care ecosystem often stretch resources thin, AI-powered startups are emerging as powerful catalysts for change. Startups powered by AI are at the forefront of this transformative wave, offering innovative solutions that enhance medical diagnosis, improve patient monitoring, accelerate drug discovery, and optimise the overall delivery of health care services. According to NITI Aayog, the potential of AI to transform India's healthcare sector is immense. The technology offers solutions to many of the challenges faced by India's health care system, especially in terms of dealing with a shortage of health care professionals in the most remote corners of the world's most populous country. To address these longstanding gaps, the Prime Minister Narendra Modi-led government is also backing the power of AI in a significant way. In the 2025 Union Budget, over $1 billion has been earmarked to support the growth of AI-driven digital health services. Coupled with efforts to expand broadband connectivity to primary health centres under Bharat Net, these moves aim to bridge the rural-urban health care divide and empower AI-based solutions at the grassroots level. Moreover, the government's push to digitise the health care system through the National Digital Health Mission—which envisions a unified health ID for every citizen—will create massive volumes of structured data. This, in turn, provides fertile ground for the development and scaling of AI applications across the health care spectrum. India's health care system has long been challenged by overburdened hospitals, a poor doctor-to-patient ratio, and limited reach in rural areas. AI startups are tackling these issues with intelligent, real-time solutions that amplify the capabilities of health care professionals and extend care to underserved regions. Startups like Augsidius, Carewell360, and VaidhyaMegha are leading this AI-driven disruption across different segments of health care. Augsidius has developed AstraAI, an intelligent assistant for doctors that provides real-time decision support with access to over 20,000 disease profiles and clinical guidelines. On the other hand, Carewell360 is making women's health services more accessible in non-metro areas through a phygital platform that offers discreet, on-demand gynaecology consultations and wellness care. Meanwhile, VaidhyaMegha equips hospitals with cloud-based AI tools to streamline diagnostics, enhance patient management, and optimise clinical workflows—solving for both patient experience and operational efficiency. The synergy between startup innovation and government support is also being echoed in the private sector. Tata Elxsi, is investing in AI-enabled imaging tools, while Google has partnered with Indian medical device startups Forus Health and AuroLab to scale AI-led screening for diabetic retinopathy screenings to more clinics across India. Beyond direct patient care, AI is playing a crucial role in boosting operational efficiency across the healthcare value chain. Startups are building systems to automate time-consuming backend processes like appointment scheduling, electronic health records (EHR) management, and billing. AI-driven predictive analytics is enabling hospitals to forecast patient inflow, manage medical inventory, and optimise staff allocation. Chatbots and virtual assistants are handling routine queries, post-treatment follow-ups, and even mental health support, helping healthcare providers scale their services without compromising on quality. Such tools are critical for relieving pressure on India's health care professionals, allowing them to focus more on delivering core clinical care while AI handles the rest. One of the most transformative roles AI can play in India is in bridging the urban-rural divide. With the rise of telemedicine, mobile diagnostics, and voice-enabled tools in regional languages, AI is making health care more inclusive and accessible. Startups like Carewell360 and SETV, among others, are enabling patients in Tier 2 and Tier 3 cities and even remote villages to receive timely consultations, screenings, and treatment guidance. AI-powered speech and text recognition is overcoming language and literacy barriers, while mobile platforms are delivering diagnostic and follow-up services directly to patients' homes. Backed by rising smartphone penetration and national programmes like Ayushman Bharat Digital Mission (ABDM), these technologies are making health care truly location-agnostic and scalable. This article is authored by Rahul Pait, CEO, DST MATH.
